CSIMarket

Lensar Inc.  (LNSR)
Other Ticker:  
 
 
Price: $6.2400 $-0.01 -0.160%
Day's High: $6.5135 Week Perf: -2.65 %
Day's Low: $ 6.18 30 Day Perf: -6.59 %
Volume (M): 19 52 Wk High: $ 8.98
Volume (M$): $ 117 52 Wk Avg: $6.91
Open: $6.29 52 Wk Low: $5.50



 Market Capitalization (Millions $) 63
 Shares Outstanding (Millions) 10
 Employees -
 Revenues (TTM) (Millions $) 37
 Net Income (TTM) (Millions $) -23
 Cash Flow (TTM) (Millions $) -9
 Capital Exp. (TTM) (Millions $) 0

Lensar Inc.


   Company Address: 2800 Discovery Drive Orlando 32826 FL
   Company Phone Number: 536-7271   Stock Exchange / Ticker: NASDAQ LNSR
   LNSR is expected to report next financial results on August 26, 2022.


   

Stock Performances by Major Competitors

Year to Date Decrease / Increase
     
• View Complete Report
   



Solid Biosciences Inc.

Deficit Bigger Than a Year Ago by Solid Biosciences Inc in the second quarter of 2022 earnings season release

In the second quarter of 2022 earnings season Solid Biosciences Inc loss increased of $-0.22 per share compared to $-0.17 a year ago and from $-0.22 per share from the previous quarter.

Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc declared top-line has dropped by -57.04 % in the second quarter of 2022

Fulcrum Therapeutics Inc reported disastrous second quarter of 2022, where Sales faded by -57.04% to $1.88 millions and loss per share has widen to $-0.83, from the same quarter a year ago.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd announced very difficult period in the financial interval ending Jun 30 2022

In the financial interval ending Jun 30 2022 Wave Life Sciences Ltd lost money of $-0.62 per share compared to $-0.78 a year ago and from $-0.62 per share from the previous quarter.

Xometry Inc.

Xometry Inc disclosed fiscal period ending Jun 30 2022 operating shortfall of $-15.601 millions

Strong Sales growth in the fiscal period ending Jun 30 2022, by 89% to $95.62 millions helped to cut the loss to $-0.35 per share, from $-1.46 in same quarter a year ago.

Rapt Therapeutics Inc.

A restrained Top-line advance at Rapt Therapeutics Inc in the fiscal span ending Jun 30 2022

In the fiscal span ending Jun 30 2022 Rapt Therapeutics Inc decreased loss of $-0.62 per share compared to $-0.63 a year ago and improved from $-0.69 per share from the previous quarter.






 

Lensar's Segments
 
 
• View Complete Report


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JAQC's Profile

Stock Price

JAQC's Financials

Business Description

Fundamentals

Charts & Quotes

JAQC's News

Suppliers

JAQC's Competitors

Customers & Markets

Economic Indicators

JAQC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071